Guzmán PMG, Alfaro LP, López SMP, Saeb LM

Language: Spanish
References: 6
Page: s64-68
PDF size: 253.74 Kb.

ABSTRACT

Pityriasis rosea is a dermatological disease caused by herpes virus 6-7 (HHV), it usually occurs during winter and early spring. During the SARS-Cov2 virus pandemic, its incidence has increased up to 5 times in dermatological clinics and out-of-hospital clinics. There have also been cases associated with the COVID-19 disease, being able to present before the symptoms, together with them and later. The hematological effects of the SARS-Cov2 virus, especially lymphopenia, could have a physiopathogenic factor in the activation of viruses.

REFERENCES

1. Drago F, Ciccarese G, Rebora A, Parodi A. Human herpesvirus-6, -7 and Epstein Barr virus reactivation in pitiriasis rosea during COVID-19. J Med Virol. 2020; 93 (4): 1850-1851. doi: 10.1002/jmv.26549.

2. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. J Eur Acad Dermatol Venereol. 2020; 34 (9): e436-e437. doi: 10.1111 / jdv.16579.

3. Galván CC, Català A, Carretero HG, Rodríguez-Jiménez P, Fernández ND, Rodríguez-Villa LA et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020; 183 (1): 71-77.

4. Dursun R, Temiz SA. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease. Dermatol Ther. 2020; 33 (4): e13730. doi: 10.1111/dth.13730.

5. Merhy R, Sarkis AS, Stephan F. Pityriasis rosea as a leading manifestation of COVID-19 infection. J Eur Acad Dermatol Venereol. 2021; 35 (4): e246-e247. Available in: 10.1111/jdv.17052. doi: 10.1111/jdv.17052.

6. Enguix DM, Salazar NMC, Romero MDT. Erupción tipo pitiriasis rosada de Gibert en una paciente asintomática con positividad para COVID-19. Med Clin (Barc). 2020;155 (6): 273.